By a News Reporter-Staff News Editor at Pharma Business Week Paragon BioTeck, Inc., a privately-held pharmaceutical and medical device company, announced that it has entered into a multi-year agreement with global healthcare supplier Perrigo Company plc to promote the ilast range of products for eyelid hygiene in the United States.
Strides Arcolab Limited, a pharmaceutical company, through its wholly owned subsidiary Strides Pharma Global Pte Limited, has agreed to acquire a portfolio of six branded prescription products, from Aspen Global Incorporated, a pharmaceuticals company and wholly owned subsidiary of Aspen Pharmacare, for a purchase consideration of approximately USD
Janssen Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration approved under priority review the New Drug Application for the three-month long-acting atypical antipsychotic INVEGA TRINZA. The results of the phase 3 study were published in March by JAMA Psychiatry, a peer-reviewed medical journal published by the American.
Deal Type: Asset Transaction Deal Country: South Africa Deal Status: Announced Deal Value: 133.9840 USD. Aspen Pharmacare Ltd., a supplier of branded and generic pharmaceuticals and a wholly owned subsidiary of Aspen Pharmacare Holdings Ltd., intends to divest business unit which forms part of its pharmaceutical division to Litha Pharma Ltd., a div
The Allowing Greater Access to Safe and Effective Contraception Act would incentivize manufacturers of routine-use contraceptives to file for a prescription-to-over-the-counter switch by allowing for priority review of the application and waiving the FDA filing fee. These incentives would be available for any contraceptive available to adults...
Nutra Pharma Corp. reported that it has engaged the Nature's Clinic to begin the process of regulatory approval of the Company's Over-the-Counter pain drug, Nyloxin for marketing and distribution in Canada. "We recently announced our plans for distribution in India and China," stated Rik J Deitsch, Chairman and CEO of Nutra Pharma Corp. "I'm excit
WASHINGTON, May 20 The Department of Health& Human Services published the following proposed rule in the Federal Register from the Food& Drug Administration:. A Proposed Rule by the Food and Drug Administration on 05/20/2015. The Animal Drug User Fee Amendments of 2008 amended the Federal Food, Drug, and Cosmetic Act to require that sponsors of a
Lannett Company, Inc., a developer, manufacturer and distributor of generic pharmaceutical products, has agreed to acquire Silarx Pharmaceuticals, Inc., a manufacturer of pharmaceutical products including generic prescription and over-the-counter products, from Rohit Desai and the RD Nevada Trust, for a purchase consideration of USD42 million in ca
MedVantx, Inc., a leading provider of point-of-care medication access, adherence and direct-to-patient consumer engagement programs, today announced the Company's MedStart Formulary Connect? program. This innovative program equips leading health systems and ACOs with new formulary management tools that are designed to build greater alignment an
As quoted in the Drug Store News, Joseph Papa, Perrigo chairman, CEO and president, believes that " Rx-to-OTC switches are expected to continue, with more than $10 billion in branded prescription sales likely to switch in the next five years.". Other factors in switch popularity are the FDA's consideration of ways that can make the transition of dr
Janssen Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration approved under priority review the New Drug Application for the three-month long-acting atypical antipsychotic INVEGA TRINZA?. The results of the phase 3 study were published in March by JAMA Psychiatry, a peer-reviewed medical journal published by the Americ
DUBLIN and WOODCLIFF LAKE, N.J., May 18, 2015/ PRNewswire/. Transaction valued at $8.05 billion is transformative for Endo, creating a powerful platform for future growth and further strategic M&A Creates specialty pharmaceutical company with one of industry's fastest growing generics businesses and expanded product portfolio, pipeline, technolog
The results presented today are among a total of 15 presentations related to INVOKANA made at the 20th Annual Meeting of the International Society for Pharmacoeconomics and Outcomes Research in Philadelphia, held May 16 to 20. "These data show INVOKANA provides significant reductions in A1C in people with type 2 diabetes seen in everyday cli
BALTIMORE, MD and TAMPA, FL 05/18/15 Romark Laboratories, a Tampa- based pharmaceutical company committed to the discovery, development and commercialization of innovative small molecules for treating infectious diseases, and Lupin Pharmaceuticals Inc., the 6th largest pharmaceutical company in the US with a wide portfolio of generic and bran